TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Artrya Limited ( (AU:AYA) ) just unveiled an update.
Artrya Limited has announced the quotation of 200,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code AYA, effective from October 10, 2025. This move is part of the company’s strategy to enhance its market presence and potentially attract more investors, reflecting its ongoing commitment to growth and development in the healthcare sector.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on developing innovative solutions for the diagnosis and management of coronary artery disease. The company leverages advanced technology to provide healthcare professionals with tools to improve patient outcomes in cardiovascular health.
Average Trading Volume: 671,503
Technical Sentiment Signal: Buy
Current Market Cap: A$402.1M
For detailed information about AYA stock, go to TipRanks’ Stock Analysis page.